Phase II Trial of Ceritinib in Combination With Stereotactic Ablative Radiation in ALK-rearranged Metastatic Lung Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Ceritinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 24 Sep 2015 Planned initiation date changed from 1 Aug 2015 to 1 Oct 2015, as reported by ClinicalTrials.gov.
- 06 Aug 2015 New trial record